10.1016/j.tips.2007.06.003 33 KushnerR
Economic Impact of Patent Expiry In the GLP-1 segment, the shift from branded therapies to biosimilars and generics will: Reduce drug prices significantly over time Increase patient access, especially in price-sensitive markets Expand total treatment volumes This volume expansion will directly increase demand for drug delivery devices, particularly disposable injection systems
O'Leary says most of those won't help your love life
FOLLOW US Asia SS Industries Quality, Innovation & Trust Our Recipe for Success Built with precision and powered by experience, our equipment ensures efficiency, safety, and reliability in every kitchen we serve
It is a science-based treatment designed to support the systems involved in appetite, blood sugar regulation, and metabolism
The company hopes to capture a large share of Indias semaglutide market, which Lupin chief financial officer Ramesh Swaminathan said in an interview with CNBC could be worth $1 billion per year